NexgenRx Inc.
NEGXFOTCHealthcare● Active
$0.27
+$0.00(+0.00%)
Market Cap$19201626
P/E Ratio—
52W High$0.28
52W Low$0.19
NexgenRx Inc. (NEGXF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NEGXF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $17.46M | $16.48M | $13.85M | $12.46M | $11.88M |
| Cost of Revenue | $4.22M | $3.35M | $3.03M | $3.97M | $3.39M |
| Gross Profit | $13.25M | $13.12M | $10.82M | $8.49M | $8.49M |
| Gross Margin %(computed) | 75.85% | 79.65% | 78.14% | 68.16% | 71.47% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.73M | $0.74M | $0.88M | $0.75M |
| Total Operating Expenses | $11.47M | $11.92M | $10.96M | $8.42M | $6.33M |
| Operating Income | $1.78M | $1.20M | ($0.14M) | $0.08M | $2.16M |
| Operating Margin %(computed) | 10.17% | 7.27% | -1.04% | 0.64% | 18.20% |
| Interest Income | $0.46M | ($0.14M) | ($0.12M) | $0.21M | $0.05M |
| Interest Expense | $0.17M | $0.03M | $0.04M | $0.15M | $0.19M |
| Income Before Tax | $1.93M | $1.03M | ($0.31M) | $0.13M | $2.03M |
| Income Tax Expense | $0.65M | $0.41M | $0.03M | $0.16M | ($2.02M) |
| Net Income | $1.29M | $0.61M | ($0.33M) | ($0.02M) | $4.05M |
| Net Margin %(computed) | 7.38% | 3.73% | -2.40% | -0.18% | 34.09% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.01 | $0.01 | $-0.00 | $-0.00 | $0.06 |
| Wtd Avg Shares | 71.12M | 70.93M | 70.53M | 70.34M | 70.34M |
| EBITDA | $3.00M | $2.32M | $1.03M | $1.68M | $4.33M |
| EBITDA Margin %(computed) | 17.16% | 14.11% | 7.45% | 13.47% | 36.49% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more NexgenRx Inc. data
About NexgenRx Inc. (NEGXF) Income Statement
NexgenRx Inc. (NEGXF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NEGXF reported revenue of $0.02B, gross profit of $0.01B (gross margin 75.85%), and net income of $0.00B — a net profit margin of 7.38%.
Frequently asked questions
NEGXF · 4 questionsNexgenRx Inc. (NEGXF) reported revenue of $0.02B for 2025, up 6.0% year-over-year.
NEGXF revenueNEGXF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09